The Effect of Neuroathletic Training in Cross-country Skiers

March 4, 2025 updated by: Nurcan Contarli, Karabuk University

The Effect of Neuroathletic Training on Physical Performance and Position Sense in Cross-country Skiers

The aim of this study was to investigate the effects of neuro-athletic training on physical performance and position sense in cross-country skiers.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Cross-country skiing is the least dangerous but tiring winter sport performed in snowy environments with different heights, distances, and slopes using ski equipment such as skis, shoes, and poles with various features. In this sport, both the lower and upper body require rapid power production and high maximal oxygen consumption. When technique, conditioning, and skill are combined in cross-country skiing, the resulting performance reaches the highest level. In order for an athlete to perform well, they must have the capacity to produce power continuously and quickly. Cross-country skiing is often associated with the development of strength, speed, agility, balance, endurance, fatigue resistance, and oxygen capacity. Physical training alone is not enough for an athlete to achieve high success. Physical training must be combined with the visual system, vestibular system, and proprioceptive system. The quality of the stimuli coming from these systems in an athlete positively affects the athlete's physical performance and success in competitions. Therefore, in addition to the physical training that the athlete will do, neuro-athletic training that stimulates the visual, vestibular, and proprioceptive systems will be implemented in the cross-country skiing sports branch, considering that it can increase the athlete's performance by improving muscle strength, core endurance, balance, and proprioceptive sense. The sample of the study will consist of 26 cross-country skiing athletes between the ages of 12-18 who participate in training at the Arkut Cross-Country and Biathlon Center. The athletes will be randomly divided into 2 groups by coin toss method. All athletes will participate in routine training. Neuroathletic training will be given to one group in addition to routine training, and its effect on the athletes' performance will be examined.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
28

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
      • Bolu, Turkey
        • Arkut Cross-Country Skiing and Biathlon Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Have been cross-country skiing for at least 3 years and regularly participate in training
  • Be a volunteer
  • Complete a Trail Making Test

Exclusion Criteria:

  • Have had lower extremity surgery in the last 2 years
  • Have no neurological or orthopedic disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Conventional Training
Conventional training includes flexibility exercises, strengthening exercises, running, balance and sport-specific technique work 5 days per week.
Other: Conventional training
Conventional training includes flexibility exercises, strengthening exercises, running, balance and sport-specific technique work 5 days per week.
Experimental: Neuro athletic training
Conventional training includes flexibility exercises, strengthening exercises, running, balance, and sport-specific technique work 5 days per week.Neuro athletic training includes exercises that stimulate the visual, vestibular and proprioceptive systems. The neuroathletic training includes 3 days per week for 8 weeks.
Other: Conventional training
Conventional training includes flexibility exercises, strengthening exercises, running, balance and sport-specific technique work 5 days per week.
Other: Neuro athletic training
The neuroathletic training includes exercises that stimulate the visual, vestibular, and proprioceptive systems. The neuroathletic training includes 3 days per week for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Knee Joint Position Sense
Time Frame: 8 weeks
Knee joint position sense will be measured using the passive-active repositioning method with a digital inclinometer.
8 weeks
Dynamic balance
Time Frame: 8 weeks
Dynamic balance will be evaluated with the Y balance test.
8 weeks
Muscle strength
Time Frame: 8 weeks
Knee flexion and extension isometric muscle strength will be measured with a handheld dynamometer.
8 weeks
Trunk Flexion Endurance Test
Time Frame: 8 weeks
The time that athletes can maintain a stance with their trunk at 60° flexion and their hips and knees at 90° flexion will be measured with a stopwatch.
8 weeks
Side Bridge Endurance Test
Time Frame: 8 weeks
Athletes will be asked to perform a side bridge in a side-lying position, with legs extended, one foot in front of the other, the body in a straight line, with the elbow joint flexed on the same side, supported by the forearm. The time they can maintain this position will be recorded with a stopwatch.
8 weeks
Slalom Test
Time Frame: 8 weeks
For this test, 6 cones will be placed on a 12-meter track at 2-meter intervals. Athletes were asked to run between the cones at maximum speed and the elapsed time will be recorded with a stopwatch.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Karabuk University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Necmiye UnYildirim Professor, PhD, Saglik Bilimleri Universitesi
  • Study Director: Caglar Soylu Assistant Professor, PhD, Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 1, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 16, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 16, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 4, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KarabukUniv-FTR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings